Literature DB >> 32668436

Anhedonia in Depressive Disorder: A Narrative Review.

Jürgen De Fruyt1, Bernard Sabbe2,3, Koen Demyttenaere4.   

Abstract

Since the introduction of DSM-III anhedonia has become a core depressive criterion and is defined as the loss of interest or pleasure. Although the origin of the word goes back to the end of the 19th century and numerous anhedonic symptoms are described in classic texts on depression, this centrality in the diagnosis of depression is only recent. Anhedonia is best described as a symptom complex with unclear boundaries cutting across the tripartite model of the mind (affect, volition, and cognition). Popular concepts of anhedonia pertain to the pleasure cycle and positive affectivity. These concepts partially overlap and are often mixed up, but clearly stem from different theoretical backgrounds: the affective science of reward processing versus more general, dimensional modelling of affect. The former concept seems more suitable to understand anhedonic emotions, the latter more suitable to understand anhedonic mood or trait. This narrative review covers the history of "anhedonia," the different anhedonic phenomena, and psychopathological concepts. An attempt is made to go beyond a merely descriptive psychopathology. Neurobiological and psychological insights shed a light on how symptoms are made and interconnected; these insights possibly call for a new psychopathological language.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Anhedonia; Depressive disorder; Major depressive disorder; Pleasure

Mesh:

Year:  2020        PMID: 32668436     DOI: 10.1159/000508773

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  9 in total

1.  Anhedonia in Eating Disorders.

Authors:  Susan M Murray; Carina S Brown; Walter H Kaye; Christina E Wierenga
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  The diagnostic and predictive potential of personality traits and coping styles in major depressive disorder.

Authors:  Cyrus S H Ho; J Chua; Gabrielle W N Tay
Journal:  BMC Psychiatry       Date:  2022-04-28       Impact factor: 4.144

3.  Mood Disturbances Across the Continuum of Care Based on Self-Report and Clinician Rated Measures in the interRAI Suite of Assessment Instruments.

Authors:  John P Hirdes; John N Morris; Christopher M Perlman; Margaret Saari; Gustavo S Betini; Manuel A Franco-Martin; Hein van Hout; Shannon L Stewart; Jason Ferris
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 5.435

4.  Anhedonia, positive affect dysregulation, and risk and maintenance of binge-eating disorder.

Authors:  Tyler B Mason; Kathryn E Smith; Lisa M Anderson; Vivienne M Hazzard
Journal:  Int J Eat Disord       Date:  2020-12-09       Impact factor: 4.861

5.  Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.

Authors:  Roger S McIntyre; Henrik Loft; Michael Cronquist Christensen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-22       Impact factor: 2.570

6.  Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Authors:  Murilo S de Abreu; Fabiano Costa; Ana C V V Giacomini; Konstantin A Demin; Konstantin N Zabegalov; Gleb O Maslov; Yuriy M Kositsyn; Elena V Petersen; Tatiana Strekalova; Denis B Rosemberg; Allan V Kalueff
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

7.  The anti-anxiety/depression effect of a combined complex of casein hydrolysate and γ-aminobutyric acid on C57BL/6 mice.

Authors:  Lei Cai; Qian Tao; Wenzhi Li; Xiping Zhu; Chun Cui
Journal:  Front Nutr       Date:  2022-09-28

8.  Exploring anhedonia in adolescents with Chronic Fatigue Syndrome (CFS): A mixed-methods study.

Authors:  Lucie Smith; Esther Crawley; Madeleine Riley; Megan McManus; Maria Elizabeth Loades
Journal:  Clin Child Psychol Psychiatry       Date:  2021-04-16       Impact factor: 2.544

9.  Molecular and functional properties of cortical astrocytes during peripherally induced neuroinflammation.

Authors:  Blanca Diaz-Castro; Alexander M Bernstein; Giovanni Coppola; Michael V Sofroniew; Baljit S Khakh
Journal:  Cell Rep       Date:  2021-08-10       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.